25/11/2025
The Combination of Carvedilol and Simvastatin Improves Portal Hypertension Control and Inflammatory Markers in Patients with Cirrhosis
Researchers from the Sant Pau Research Institute (IR Sant Pau) have conducted a clinical trial demonstrating that the combination of two widely available drugs, carvedilol and simvastatin, significant...